• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用生物信息学和机器学习识别肺腺癌的预后生物标志物并预测临床结果。

Leveraging Bioinformatics and Machine Learning for Identifying Prognostic Biomarkers and Predicting Clinical Outcomes in Lung Adenocarcinoma.

作者信息

Cai Kaida, Fu Wenzhi, Liu Hanwen, Yang Xiaofang, Wang Zhengyan, Zhao Xin

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China.

Department of Statistics and Actuarial Science, School of Mathematics, Southeast University, Nanjing 211189, China.

出版信息

Genes (Basel). 2024 Nov 21;15(12):1497. doi: 10.3390/genes15121497.

DOI:10.3390/genes15121497
PMID:39766765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11675206/
Abstract

There exist significant challenges for lung adenocarcinoma (LUAD) due to its poor prognosis and limited treatment options, particularly in the advanced stages. It is crucial to identify genetic biomarkers for improving outcome predictions and guiding personalized therapies. In this study, we utilize a multi-step approach that combines principled sure independence screening, penalized regression methods and information gain to identify the key genetic features of the ultra-high dimensional RNA-sequencing data from LUAD patients. We then evaluate three methods of survival analysis: the Cox model, survival tree, and random survival forests (RSFs), to compare their predictive performance. Additionally, a protein-protein interaction network is used to explore the biological significance of identified genes. and are consistently selected as significant predictors across all feature selection methods. The Kaplan-Meier method shows that high expression levels of these genes are strongly correlated with poorer survival outcomes, suggesting their potential as prognostic biomarkers. RSF outperforms Cox and survival tree methods, showing higher AUC and C-index values. The protein-protein interaction network highlights key nodes such as and , which play central roles in LUAD progression. Our findings provide valuable insights into the genetic mechanisms of LUAD. These results contribute to the development of more accurate prognostic tools and personalized treatment strategies for LUAD.

摘要

由于预后不良和治疗选择有限,尤其是在晚期阶段,肺腺癌(LUAD)面临着重大挑战。识别基因生物标志物对于改善预后预测和指导个性化治疗至关重要。在本研究中,我们采用了一种多步骤方法,该方法结合了有原则的确定独立筛选、惩罚回归方法和信息增益,以识别来自LUAD患者的超高维RNA测序数据的关键基因特征。然后,我们评估了三种生存分析方法:Cox模型、生存树和随机生存森林(RSF),以比较它们的预测性能。此外,利用蛋白质-蛋白质相互作用网络来探索已识别基因的生物学意义。在所有特征选择方法中,[具体基因1]和[具体基因2]一直被选为显著预测因子。Kaplan-Meier方法表明,这些基因的高表达水平与较差的生存结果密切相关,表明它们作为预后生物标志物的潜力。RSF优于Cox模型和生存树方法,具有更高的AUC和C指数值。蛋白质-蛋白质相互作用网络突出了[关键节点基因1]和[关键节点基因2]等关键节点,它们在LUAD进展中起核心作用。我们的研究结果为LUAD的遗传机制提供了有价值的见解。这些结果有助于开发更准确的LUAD预后工具和个性化治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/aa68b73af8f6/genes-15-01497-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/9232d1e5f169/genes-15-01497-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/096cb0fb66dd/genes-15-01497-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/2265b5cd51e7/genes-15-01497-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/3466117413fd/genes-15-01497-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/558dc48e23da/genes-15-01497-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/4bb92fbfeb31/genes-15-01497-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/aa68b73af8f6/genes-15-01497-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/9232d1e5f169/genes-15-01497-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/096cb0fb66dd/genes-15-01497-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/2265b5cd51e7/genes-15-01497-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/3466117413fd/genes-15-01497-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/558dc48e23da/genes-15-01497-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/4bb92fbfeb31/genes-15-01497-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2278/11675206/aa68b73af8f6/genes-15-01497-g007.jpg

相似文献

1
Leveraging Bioinformatics and Machine Learning for Identifying Prognostic Biomarkers and Predicting Clinical Outcomes in Lung Adenocarcinoma.利用生物信息学和机器学习识别肺腺癌的预后生物标志物并预测临床结果。
Genes (Basel). 2024 Nov 21;15(12):1497. doi: 10.3390/genes15121497.
2
SMR-guided molecular subtyping and machine learning model reveals novel prognostic biomarkers and therapeutic targets in non-small cell lung adenocarcinoma.基于表面肌电引导的分子亚型分析及机器学习模型揭示非小细胞肺腺癌新的预后生物标志物和治疗靶点。
Sci Rep. 2025 Jan 10;15(1):1640. doi: 10.1038/s41598-025-85471-8.
3
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.一项通过机器学习策略确定肺腺癌新预后预测模型的大型队列研究。
BMC Cancer. 2019 Sep 5;19(1):886. doi: 10.1186/s12885-019-6101-7.
4
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.预测涉及人肺腺癌进展的失调竞争内源性 RNA 特征。
Cancer Biomark. 2020;29(3):399-416. doi: 10.3233/CBM-200133.
5
Integrating multi-omics and machine learning survival frameworks to build a prognostic model based on immune function and cell death patterns in a lung adenocarcinoma cohort.整合多组学和机器学习生存框架,基于肺腺癌队列中的免疫功能和细胞死亡模式构建预后模型。
Front Immunol. 2024 Sep 13;15:1460547. doi: 10.3389/fimmu.2024.1460547. eCollection 2024.
6
Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.全面分析 TPX2 相关 ceRNA 网络作为肺腺癌的预后生物标志物。
Int J Med Sci. 2020 Sep 1;17(16):2427-2439. doi: 10.7150/ijms.49053. eCollection 2020.
7
A bioinformatics exploration of lung adenocarcinoma identifies hub genes with prognostic significance: from data to discovery.一项关于肺腺癌的生物信息学探索确定了具有预后意义的关键基因:从数据到发现。
J Egypt Natl Canc Inst. 2025 May 5;37(1):15. doi: 10.1186/s43046-025-00273-3.
8
Immunoinfiltration Analysis of Mitochondrial Damage-Related Genes in Lung Adenocarcinoma and Construction of a Classification and Prognostic Model Integrated With WGCNA and Machine Learning Algorithms.肺腺癌中线粒体损伤相关基因的免疫浸润分析及结合WGCNA和机器学习算法构建分类与预后模型
Cancer Med. 2025 Jan;14(2):e70590. doi: 10.1002/cam4.70590.
9
Development and functional validation of a disulfidoptosis-related gene prognostic model for lung adenocarcinoma based on bioinformatics and experimental validation.基于生物信息学和实验验证的肺腺癌二硫键凋亡相关基因预后模型的构建与功能验证
Front Immunol. 2025 Feb 10;16:1540578. doi: 10.3389/fimmu.2025.1540578. eCollection 2025.
10
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.新型基质/免疫评分相关 P2RY12 在肺腺癌微环境中的预后价值及免疫浸润分析。
Int Immunopharmacol. 2021 Sep;98:107734. doi: 10.1016/j.intimp.2021.107734. Epub 2021 Jun 25.

本文引用的文献

1
LINC01116-dependent upregulation of RNA polymerase I transcription drives oncogenic phenotypes in lung adenocarcinoma.LINC01116 依赖性 RNA 聚合酶 I 转录上调驱动肺腺癌的致癌表型。
J Transl Med. 2024 Oct 5;22(1):904. doi: 10.1186/s12967-024-05715-5.
2
Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion.分子分类揭示了肺腺癌对放疗和免疫治疗的敏感性:基于相似网络融合的多组学聚类。
Cancer Immunol Immunother. 2024 Mar 2;73(4):71. doi: 10.1007/s00262-024-03657-x.
3
The E2F1/MELTF axis fosters the progression of lung adenocarcinoma by regulating the Notch signaling pathway.
E2F1/MELTF 轴通过调节 Notch 信号通路促进肺腺癌的进展。
Mutat Res. 2023 Jul-Dec;827:111837. doi: 10.1016/j.mrfmmm.2023.111837. Epub 2023 Sep 28.
4
Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironment.肺腺癌中与耐药相关的基因可预测患者预后并影响肿瘤微环境。
Sci Rep. 2023 Jun 15;13(1):9682. doi: 10.1038/s41598-023-35743-y.
5
ARNTL2 upregulation of ACOT7 promotes NSCLC cell proliferation through inhibition of apoptosis and ferroptosis.ARNTL2 上调 ACOT7 通过抑制细胞凋亡和铁死亡促进非小细胞肺癌细胞增殖。
BMC Mol Cell Biol. 2023 Mar 31;24(1):14. doi: 10.1186/s12860-022-00450-5.
6
Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.鉴定用于预测肺腺癌预后和免疫治疗疗效的N7-甲基鸟苷相关特征
Front Med (Lausanne). 2022 Aug 24;9:962972. doi: 10.3389/fmed.2022.962972. eCollection 2022.
7
Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma.鉴定肺腺癌 mRNA 疫苗相关的新型肿瘤相关抗原和免疫表型。
Int Immunopharmacol. 2022 Aug;109:108816. doi: 10.1016/j.intimp.2022.108816. Epub 2022 Apr 30.
8
cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines.cSurvival:一个用于癌症结果和细胞系中生物标志物相互作用的网络资源。
Brief Bioinform. 2022 May 13;23(3). doi: 10.1093/bib/bbac090.
9
A Systematic Evaluation of Supervised Machine Learning Algorithms for Cell Phenotype Classification Using Single-Cell RNA Sequencing Data.使用单细胞RNA测序数据对用于细胞表型分类的监督机器学习算法的系统评估
Front Genet. 2022 Feb 23;13:836798. doi: 10.3389/fgene.2022.836798. eCollection 2022.
10
RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.RHOV 通过 JNK/c-Jun 通路促进肺腺癌细胞的生长和转移。
Int J Biol Sci. 2021 Jun 22;17(10):2622-2632. doi: 10.7150/ijbs.59939. eCollection 2021.